10-Q Filing

NEOGENOMICS INC CIK: 1077183 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001564590-17-023566`
Period End Date	20170930
Filing Date	20171113
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	neo-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 86 Cash Flow Statement 70

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivable`	$13.70M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivable`	$10.94M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$27.10M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$37.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.53M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.93M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.21M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $10,937 and $13,699, respectively)	`AccountsReceivableNetCurrent`	$62.72M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $10,937 and $13,699, respectively)	`AccountsReceivableNetCurrent`	$55.51M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	78.57M	shares	Point-in-time
Inventories	`InventoryNet`	$6.25M	USD	Point-in-time
Inventories	`InventoryNet`	$6.09M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	80.35M	shares	Point-in-time
Other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.72M	USD	Point-in-time
Other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.54M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	80.35M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	78.57M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$85.75M	USD	Point-in-time
Redeemable Convertible Preferred Stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$78.83M	USD	Point-in-time
Redeemable Convertible Preferred Stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment (net of accumulated depreciation of $37,496 and $27,102, respectively)	`PropertyPlantAndEquipmentNet`	$34.04M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares authorized	`TemporaryEquitySharesAuthorized`	50.00M	shares	Point-in-time
Property and equipment (net of accumulated depreciation of $37,496 and $27,102, respectively)	`PropertyPlantAndEquipmentNet`	$34.55M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares authorized	`TemporaryEquitySharesAuthorized`	50.00M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$76.33M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$77.06M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	6.60M	shares	Point-in-time
Redeemable Convertible Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	6.60M	shares	Point-in-time
Redeemable Convertible Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	6.60M	shares	Point-in-time
Goodwill	`Goodwill`	$147.02M	USD	Point-in-time
Goodwill	`Goodwill`	$147.02M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	6.60M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$250.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$174.00K	USD	Point-in-time
Total assets	`Assets`	$337.12M	USD	Point-in-time
Total assets	`Assets`	$343.89M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$16.78M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$14.82M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$11.80M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$8.35M	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$4.25M	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$5.00M	USD	Point-in-time
Short-term portion of capital leases	`CapitalLeaseObligationsCurrent`	$4.89M	USD	Point-in-time
Short-term portion of capital leases	`CapitalLeaseObligationsCurrent`	$4.69M	USD	Point-in-time
Short-term portion of loans	`SecuredDebtCurrent`	$3.80M	USD	Point-in-time
Short-term portion of loans	`SecuredDebtCurrent`	$3.84M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$40.11M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$38.11M	USD	Point-in-time
Long-term portion of capital leases	`CapitalLeaseObligationsNoncurrent`	$5.38M	USD	Point-in-time
Long-term portion of capital leases	`CapitalLeaseObligationsNoncurrent`	$4.58M	USD	Point-in-time
Long-term portion of loans, net	`SecuredLongTermDebt`	$70.26M	USD	Point-in-time
Long-term portion of loans, net	`SecuredLongTermDebt`	$67.53M	USD	Point-in-time
Revolving credit facility, net	`LongTermLineOfCredit`	$21.80M	USD	Point-in-time
Revolving credit facility, net	`LongTermLineOfCredit`	$24.46M	USD	Point-in-time
Deferred income tax liability, net	`DeferredTaxLiabilities`	$14.97M	USD	Point-in-time
Deferred income tax liability, net	`DeferredTaxLiabilities`	$7.55M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$112.41M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$104.12M	USD	Point-in-time
Total liabilities	`Liabilities`	$144.24M	USD	Point-in-time
Total liabilities	`Liabilities`	$150.52M	USD	Point-in-time
Commitments and contingencies - see Note I	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies - see Note I	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series A Redeemable Convertible Preferred Stock, $0.001 par value, (50,000,000 shares authorized; 6,600,000 shares issued and outstanding)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$22.87M	USD	Point-in-time
Series A Redeemable Convertible Preferred Stock, $0.001 par value, (50,000,000 shares authorized; 6,600,000 shares issued and outstanding)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$30.12M	USD	Point-in-time
Common stock, $0.001 par value, (250,000,000 shares authorized; 80,346,946 and 78,571,158 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$79.00K	USD	Point-in-time
Common stock, $0.001 par value, (250,000,000 shares authorized; 80,346,946 and 78,571,158 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$80.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$216.10M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$229.01M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-59.55M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-52.46M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$163.72M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$169.53M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$343.89M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$337.12M	USD	Point-in-time

Income Statement 86 line items

Line Item	Tag	Value	Unit	Period
Clinical testing	`ClinicalTestingRevenue`	$166.67M	USD	3 Qtrs
Clinical testing	`ClinicalTestingRevenue`	$55.74M	USD	1 Quarter
Clinical testing	`ClinicalTestingRevenue`	$172.67M	USD	3 Qtrs
Clinical testing	`ClinicalTestingRevenue`	$56.19M	USD	1 Quarter
Pharma Services	`PharmaServices`	$6.87M	USD	1 Quarter
Pharma Services	`PharmaServices`	$16.92M	USD	3 Qtrs
Pharma Services	`PharmaServices`	$5.02M	USD	1 Quarter
Pharma Services	`PharmaServices`	$18.15M	USD	3 Qtrs
Total Revenue	`SalesRevenueServicesNet`	$60.76M	USD	1 Quarter
Total Revenue	`SalesRevenueServicesNet`	$190.82M	USD	3 Qtrs
Total Revenue	`SalesRevenueServicesNet`	$183.59M	USD	3 Qtrs
Total Revenue	`SalesRevenueServicesNet`	$63.05M	USD	1 Quarter
COST OF REVENUE	`CostOfServices`	$33.42M	USD	1 Quarter
COST OF REVENUE	`CostOfServices`	$100.47M	USD	3 Qtrs
COST OF REVENUE	`CostOfServices`	$34.24M	USD	1 Quarter
COST OF REVENUE	`CostOfServices`	$103.63M	USD	3 Qtrs
GROSS PROFIT	`GrossProfit`	$83.12M	USD	3 Qtrs
GROSS PROFIT	`GrossProfit`	$27.34M	USD	1 Quarter
GROSS PROFIT	`GrossProfit`	$87.18M	USD	3 Qtrs
GROSS PROFIT	`GrossProfit`	$28.81M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$55.81M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$66.74M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$19.02M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$23.27M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.72M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$967.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.08M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.27M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$6.58M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$18.47M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$5.96M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$18.08M	USD	3 Qtrs
Loss on sale of Path Logic	`GainLossOnSaleOfBusiness`	$-1.06M	USD	3 Qtrs
Loss on sale of Path Logic	`GainLossOnSaleOfBusiness`	$-1.06M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$32.17M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$25.95M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$77.61M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$89.35M	USD	3 Qtrs
INCOME (LOSS) FROM OPERATIONS	`OperatingIncomeLoss`	$-2.16M	USD	3 Qtrs
INCOME (LOSS) FROM OPERATIONS	`OperatingIncomeLoss`	$5.51M	USD	3 Qtrs
INCOME (LOSS) FROM OPERATIONS	`OperatingIncomeLoss`	$-3.36M	USD	1 Quarter
INCOME (LOSS) FROM OPERATIONS	`OperatingIncomeLoss`	$1.40M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-4.17M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-1.40M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-1.47M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-4.51M	USD	3 Qtrs
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-73.00K	USD	1 Quarter
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.76M	USD	1 Quarter
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.34M	USD	3 Qtrs
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.00M	USD	3 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$340.00K	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$500.00K	USD	3 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-539.00K	USD	3 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-6.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-5.80M	USD	3 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$500.00K	USD	3 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$-67.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-5.10M	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$1.84M	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$5.52M	USD	3 Qtrs
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$2.73M	USD	3 Qtrs
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$912.00K	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$1.74M	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$3.73M	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$5.12M	USD	3 Qtrs
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$11.18M	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.63M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-7.75M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.20M	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.65M	USD	3 Qtrs
Basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.10	USD	1 Quarter
Basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.17	USD	3 Qtrs
Basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.07	USD	1 Quarter
Basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.21	USD	3 Qtrs
Diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.10	USD	1 Quarter
Diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.17	USD	3 Qtrs
Diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.07	USD	1 Quarter
Diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.21	USD	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	79.21M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	79.62M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	77.22M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	78.14M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	79.21M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	78.14M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	79.62M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	77.22M	shares	3 Qtrs

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-5.80M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$500.00K	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-67.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-5.10M	USD	1 Quarter
Depreciation	`Depreciation`	$11.55M	USD	3 Qtrs
Depreciation	`Depreciation`	$11.74M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$5.45M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.80M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$5.20M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.70M	USD	1 Quarter
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$532.00K	USD	3 Qtrs
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$330.00K	USD	3 Qtrs
Loss on sale of Path Logic	`GainLossOnSaleOfBusiness`	$-1.06M	USD	3 Qtrs
Loss on sale of Path Logic	`GainLossOnSaleOfBusiness`	$-1.06M	USD	1 Quarter
Stock based compensation options, restricted stock and warrants	`ShareBasedCompensation`	$4.02M	USD	3 Qtrs
Stock based compensation options, restricted stock and warrants	`ShareBasedCompensation`	$5.81M	USD	3 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$8.18M	USD	3 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$13.03M	USD	3 Qtrs
(Increase) in accounts receivable, net of write-offs	`IncreaseDecreaseInAccountsReceivable`	$20.92M	USD	3 Qtrs
(Increase) in accounts receivable, net of write-offs	`IncreaseDecreaseInAccountsReceivable`	$9.42M	USD	3 Qtrs
(Increase) in inventories	`IncreaseDecreaseInInventories`	$37.00K	USD	3 Qtrs
(Increase) in inventories	`IncreaseDecreaseInInventories`	$844.00K	USD	3 Qtrs
(Increase) in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.48M	USD	3 Qtrs
(Increase) in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$406.00K	USD	3 Qtrs
(Increase) in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$98.00K	USD	3 Qtrs
(Increase) in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$46.00K	USD	3 Qtrs
Increase in accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$3.27M	USD	3 Qtrs
Increase in accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$2.37M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$12.28M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$21.72M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.33M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.17M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-10.17M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-5.33M	USD	3 Qtrs
Advances from revolving credit facility, net	`ProceedsFromLinesOfCredit`	$2.50M	USD	3 Qtrs
Repayment to revolving credit facility	`RepaymentsOfLinesOfCredit`	$10.04M	USD	3 Qtrs
Repayment of capital lease obligations/loans	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$3.87M	USD	3 Qtrs
Repayment of capital lease obligations/loans	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$4.13M	USD	3 Qtrs
Repayment on term loan, net	`RepaymentsOfLongTermLinesOfCredit`	$2.82M	USD	3 Qtrs
Repayment on term loan, net	`RepaymentsOfLongTermLinesOfCredit`	$413.00K	USD	3 Qtrs
Proceeds from the exercise of options, warrants and ESPP shares, net of transaction expenses	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$3.46M	USD	3 Qtrs
Proceeds from the exercise of options, warrants and ESPP shares, net of transaction expenses	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$2.22M	USD	3 Qtrs
Payments of equity issue costs	`PaymentsOfStockIssuanceCosts`	$197.00K	USD	3 Qtrs
Net cash (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-10.88M	USD	3 Qtrs
Net cash (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-2.42M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$5.51M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-314.00K	USD	3 Qtrs
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.53M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$28.93M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.21M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.53M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$28.93M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.21M	USD	Point-in-time
Interest paid	`InterestPaid`	$3.99M	USD	3 Qtrs
Interest paid	`InterestPaid`	$3.88M	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$272.00K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$228.00K	USD	3 Qtrs
Equipment acquired under capital lease/loan obligations	`CapitalLeaseObligationsIncurred`	$3.24M	USD	3 Qtrs
Equipment acquired under capital lease/loan obligations	`CapitalLeaseObligationsIncurred`	$4.91M	USD	3 Qtrs
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$1.84M	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$5.52M	USD	3 Qtrs
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$2.73M	USD	3 Qtrs
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$912.00K	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$1.74M	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$3.73M	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$5.12M	USD	3 Qtrs
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$11.18M	USD	3 Qtrs
Purchase of customer list through issuance of restricted stock	`PurchaseOfCustomerListThroughIssuanceOfRestrictedStock`	$4.47M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.